John Schieszer, MA

John Schieszer is a medical journalist based in Seattle, Washington.

Most Recent Articles by John Schieszer, MA

Continuous Therapy May Be Beneficial in Patients With Newly Diagnosed Multiple Myeloma

Continuous Therapy May Be Beneficial in Patients With Newly Diagnosed Multiple Myeloma

By

Continuous therapy appears to be the preferred treatment modality in newly diagnosed patients with multiple myeloma (MM).

Regular Physical Activity — Even Initiated Postdiagnosis — Improves Survival for Cancer Patients

Regular Physical Activity — Even Initiated Postdiagnosis — Improves Survival for Cancer Patients

By

A review of DBBR data demonstrated that regular recreational physical activity may reduce the risk of all-cause and cancer-specific mortality in persons who are habitually active as a lifestyle as well as those who adopt regular exercise as a lifestyle after diagnosis.

Safe to Administer B12 Supplementation, Pemetrexed Infusions for Lung Cancers on Same Day

Safe to Administer B12 Supplementation, Pemetrexed Infusions for Lung Cancers on Same Day

By

Mean changes in hematologic indices found similar regardless of same-day or prior administration of B12 supplementation in patients receiving pemetrexed for NSCLC or pleural mesothelioma.

Nedaplatin Associated With Less Toxicity Than Cisplatin for MPE

Nedaplatin Associated With Less Toxicity Than Cisplatin for MPE

By

In this retrospective study, researchers sought to determine the efficacy of nedaplatin vs cisplatin for the treatment of malignancy-induced malignant pleural effusion.

Managing Dermatologic Adverse Events in Patients Receiving Third-Generation EGFR-TKIs

Managing Dermatologic Adverse Events in Patients Receiving Third-Generation EGFR-TKIs

By

An international team reviews osimertinib-associated dermatologic adverse events in patients treated with the third-generation EGFR-TKI.

More Articles by John Schieszer, MA

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs